Product ID: SQMIG35A2503
Report ID:
SQMIG35A2503 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
92 |
Figures:
76
North America dominated the market with a 41.6% share in 2022, owing mostly to the rising frequency of respiratory disorders. As the number of COPD and asthma cases rises, so does the usage of spirometers, which help in disease control and are routinely used by doctors in hospitals. Furthermore, the US has been highlighted as an early adopter of technology that aids in the decrease of COPD rates. Due to the one preceding, the market is expected to expand throughout the forecast period.
Asia Pacific, on the other hand, is predicted to develop at the quickest rate throughout the forecast period, with a CAGR (compound annual growth rate) of 11.1%. Improving primary care efforts for early detection and treatment of chronic lung diseases including COPD and asthma are expected to drive the market in the Asia-Pacific region over the projected period.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2503